Atlas Trials

A Database Survey of Comparison The Risk of Haemorrhage Between Vortioxetine Tablet Treatment and Selective Serotonin Reuptake Inhibitor (SSRI) Treatment in Participants With Depression

Clinical trial NCT05932407 · COMPLETED

Trial details

NCT number
NCT05932407
Sponsor
Takeda
Status
COMPLETED
Study type
OBSERVATIONAL
Major Depressive Disorder
Start date
2024-06-01
Primary completion
2024-09-09
Enrollment
147777

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.